PATENT CLAIM ANALYSIS

Application Number: 15910830
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-07
Patent Classification: ["514", "414000"]

Abstract:
The invention relates to (among other things) polymer-semaxanib moiety conjugates and related compounds. A compound of the invention, when administered by any of a number of administration routes, exhibits advantages over the semaxanib moiety in unconjugated form.

Claim (Index 14):
The compound of  claim 1 , wherein a single water-soluble, non-peptidic oligomer is attached to the semaxanib moiety.

Metadata:
- Claim Count in Document: 56.0
- Percentile: 90.0
- Lexical Diversity: 1.19444
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13995301', '15792060', '13995819', '14336764', '13996834']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7663429909487312
- 35 USC 102 Novelty (BERT): 0.5388022527499733
- Combined Prediction Score: 0.7435889171288554
- Mean Citation Score: 322.18016
- Max Citation Score: 358.61536
- Similarity Product: 281.5596861878967

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test